IRIS Accounts Production v26.1.10.61 16058990 director 4.11.24 31.12.25 31.12.25 false true false false true false Ordinary 0.01000 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 16058990 2024-11-03 16058990 2025-12-31 16058990 2024-11-04 2025-12-31 16058990 2024-11-03 16058990 ns14:PoundSterling 2024-11-04 2025-12-31 16058990 ns10:Director1 2024-11-04 2025-12-31 16058990 ns10:PrivateLimitedCompanyLtd 2024-11-04 2025-12-31 16058990 ns10:SmallEntities 2024-11-04 2025-12-31 16058990 ns10:AuditExempt-NoAccountantsReport 2024-11-04 2025-12-31 16058990 ns10:SmallCompaniesRegimeForDirectorsReport 2024-11-04 2025-12-31 16058990 ns10:SmallCompaniesRegimeForAccounts 2024-11-04 2025-12-31 16058990 ns10:FullAccounts 2024-11-04 2025-12-31 16058990 ns10:OrdinaryShareClass1 2024-11-04 2025-12-31 16058990 ns5:CurrentFinancialInstruments 2025-12-31 16058990 ns5:RetainedEarningsAccumulatedLosses 2025-12-31 16058990 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-12-31 16058990 ns10:OrdinaryShareClass1 2025-12-31

REGISTERED NUMBER: 16058990

UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 4 NOVEMBER 2024 TO 31 DECEMBER 2025

FOR

CLARIFY CLINICS MANAGEMENT LIMITED

CLARIFY CLINICS MANAGEMENT LIMITED (REGISTERED NUMBER: 16058990) |

CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE PERIOD 4 NOVEMBER 2024 TO 31 DECEMBER 2025

Page |

| Statement of Financial Position | 1 |

| Notes to the Financial Statements | 2 |

CLARIFY CLINICS MANAGEMENT LIMITED (REGISTERED NUMBER: 16058990) |

STATEMENT OF FINANCIAL POSITION

31 DECEMBER 2025

| Notes | £ |

| CURRENT ASSETS

| Debtors | 4 | 1,490 |  |

| Cash at bank | 5 | 185 |  |

1,675 |  |

| CREDITORS

| Amounts falling due within one year | 6 | (13,548 | ) |

| NET CURRENT LIABILITIES | (11,873 | ) |

| TOTAL ASSETS LESS CURRENT LIABILITIES | (11,873 | ) |

| RESERVES

| Retained earnings | (11,873 | ) |

| SHAREHOLDERS' FUNDS | (11,873 | ) |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 4 August 2026 and were signed by:

Professor A Belli - Director

CLARIFY CLINICS MANAGEMENT LIMITED (REGISTERED NUMBER: 16058990) |

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD 4 NOVEMBER 2024 TO 31 DECEMBER 2025

1. | GENERAL INFORMATION

| Clarify Clinics Management Limited is a private limited company (limited by shares) incorporated in England and Wales. The address of the registered office is 2nd Floor, 55 Ludgate Hill, London, United Kingdom, EC4M 7JW.

| The principal activity was that of facilitating administrative and payment processing activities in connection with healthcare services.

| These are the company's first statutory accounts since incorporation and commenced trading on 4 November 2024.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| The financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| The following accounting principles have been applied:

| Going concern

| The director considers the going concern basis to be appropriate, having paid due regard to the company’s projected results during the twelve months from the date the financial statements are approved, and the anticipated cash flows, availability of bank facilities, and mitigating actions that can be taken during that period.

| Taxation

| Tax is recognised in the Statement of income and retained earnings.

| The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates income.

| Foreign currency translation

| Functional and presentation currency

| The company's functional and presentational currency is GBP.

| Transactions and balances

| Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

| At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

| Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in the Statement of income and retained earnings except when deferred in other comprehensive income as qualifying cash flow hedges.

| Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of income and retained earnings within 'finance income or costs'. All other foreign exchange gains and losses are presented in the Statement of income and retained earnings within 'other operating income'.

| Cash and cash equivalents

| Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.

| Debtors

| Short term debtors are measured at transaction price, less any impairment.

| Creditors

| Short term creditors are measured at the transaction price.

CLARIFY CLINICS MANAGEMENT LIMITED (REGISTERED NUMBER: 16058990) |

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE PERIOD 4 NOVEMBER 2024 TO 31 DECEMBER 2025

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the period was 1 .

4. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

£ |

| Other debtors | 390 |  |

| Prepayments | 1,100 |  |

1,490 |  |

5. | CASH AT BANK

£ |

| Bank | 185 |  |

6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

£ |

| Trade creditors | 1,354 |  |

| Other creditors | 6,344 |  |

| Accruals | 5,850 |  |

13,548 |  |

7. | CALLED UP SHARE CAPITAL

| Allotted, issued and fully paid:

| Number: | Class: | Nominal

| value: | £ |

| 1 | Ordinary | 0.01 | - |  |